Forskning
Udskriv Udskriv
Switch language
Rigshospitalet - en del af Københavns Universitetshospital
Udgivet

Response to AASLD editorial/message from the president

Publikation: Bidrag til tidsskriftLetterForskningpeer review

DOI

  1. High Risk of Fatty Liver Disease Amplifies the Alanine Transaminase-Lowering Effect of a HSD17B13 Variant

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Identification and Replication of Six Loci Associated With Gallstone Disease

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Reversal of Acute Liver Failure Due to Wilson Disease by a Regimen of High-Volume Plasma Exchange and Penicillamine

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Dynamic LED-light versus static LED-light for depressed inpatients: study protocol for a randomised clinical study

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Sertraline in primary care: comments on the PANDA trial

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Vis graf over relationer

A commentary [1] criticized our systematic review regarding the use of direct-acting agents (DAAs) in chronic hepatitis C [2]. The following represents our major disagreements. Sustained virological response (SVR) is a non-validated surrogate outcome. The principles of evidence-based medicine require that it be validated in randomized clinical trials (RCTs) by showing parallel benefits in clinical outcomes [3]. This article is protected by copyright. All rights reserved.

OriginalsprogEngelsk
TidsskriftHepatology (Baltimore, Md.)
Vol/bind69
Udgave nummer5
Sider (fra-til)2300
ISSN0270-9139
DOI
StatusUdgivet - 2019

ID: 59222373